About List Biological Laboratories
List Biological Laboratories is a company based in Campbell (United States) founded in 1978 was acquired by Genome & Company in September 2021.. List Biological Laboratories has raised $48.4 million across 2 funding rounds from investors including Korea Investment Holdings, Genome & Company and DSC Investment. List Biological Laboratories offers products and services including Bacterial Toxins, Bacterial Polysaccharides, Recombinant Proteins, and Live Biotherapeutics. List Biological Laboratories operates in a competitive market with competitors including PrognomiQ, PreOmics, Vivostat, LenioBio and Expedeon, among others.
- Headquarter Campbell, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name List Biological Laboratories, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$48.4 M (USD)
in 2 rounds
-
Latest Funding Round
$17.4 M (USD), Private Equity Round
Mar 23, 2022
-
Investors
Korea Investment Holdings
& 3 more
-
Employee Count
Employee Count
-
Acquired by
Genome & Company
(Sep 08, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of List Biological Laboratories
List Biological Laboratories offers a comprehensive portfolio of products and services, including Bacterial Toxins, Bacterial Polysaccharides, Recombinant Proteins, and Live Biotherapeutics. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
High-purity toxins for disease studies and therapeutic tools.
Compounds for vaccine development and research applications.
Proteins for clinical and research use in therapies.
Manufacturing for microbiome-based therapeutic products.
Unlock access to complete
Funding Insights of List Biological Laboratories
List Biological Laboratories has successfully raised a total of $48.4M across 2 strategic funding rounds. The most recent funding activity was a Private Equity Round round of $17.4 million completed in March 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Private Equity Round — $17.4M
-
First Round
First Round
(31 Dec 2021)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2022 | Amount | Private Equity Round - List Biological Laboratories | Valuation |
investors |
|
| Dec, 2021 | Amount | Private Equity Round - List Biological Laboratories | Valuation | DSC Investment , Korea Investment Holdings |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in List Biological Laboratories
List Biological Laboratories has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Korea Investment Holdings, Genome & Company and DSC Investment. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage venture capital is invested primarily in South Korean startups.
|
Founded Year | Domain | Location | |
|
Investment holding firm established in Seoul in 2003.
|
Founded Year | Domain | Location | |
|
Operates as an investment management firm handling diversified funds and portfolios.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by List Biological Laboratories
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - List Biological Laboratories
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
List Biological Laboratories Comparisons
Competitors of List Biological Laboratories
List Biological Laboratories operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PrognomiQ, PreOmics, Vivostat, LenioBio and Expedeon, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of tests for the detection and treatment of cancer and other diseases
|
|
| domain | founded_year | HQ Location |
Reagents and instruments for proteomics research are supplied by PreOmics.
|
|
| domain | founded_year | HQ Location |
On-site fibrin sealant preparation systems are developed and provided.
|
|
| domain | founded_year | HQ Location |
Kits for cell-free eukaryotic protein expression are provided.
|
|
| domain | founded_year | HQ Location |
Reagents and kits for protein-based research are developed and supplied.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on List Biological Laboratories
Frequently Asked Questions about List Biological Laboratories
When was List Biological Laboratories founded?
List Biological Laboratories was founded in 1978 and raised its 1st funding round 43 years after it was founded.
Where is List Biological Laboratories located?
List Biological Laboratories is headquartered in Campbell, United States. It is registered at Campbell, California, United States.
Is List Biological Laboratories a funded company?
List Biological Laboratories is a funded company, having raised a total of $48.4M across 2 funding rounds to date. The company's 1st funding round was a Private Equity Round of $31M, raised on Dec 31, 2021.
What does List Biological Laboratories do?
Specializes in the production of reagents for research and custom laboratory services. The company product line includes anthrax toxins, antisera antibodies, botulinum toxins, cholera toxins, clostridial toxins, other difficile toxins, Diphtheria Toxin CRM Exotoxin, Peptides, Native Substrates Receptors, Lipopolysaccharides, Pertussis Toxins Virulence Factors, Shiga Toxins, Staphylococcal Toxins, Tetanus Toxins Related Products, Toxoids Vaccine Carrier Proteins and Adjuvants.
Who are the top competitors of List Biological Laboratories?
What products or services does List Biological Laboratories offer?
List Biological Laboratories offers Bacterial Toxins, Bacterial Polysaccharides, Recombinant Proteins, and Live Biotherapeutics.
Who are List Biological Laboratories's investors?
List Biological Laboratories has 4 investors. Key investors include Korea Investment Holdings, Genome & Company, DSC Investment, and Korea Investment Value Asset Management.